(CPB) Campbell’s - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1344291091
Soups, Broths, Sauces, Snacks, Beverages
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.86% |
| Yield on Cost 5y | 3.89% |
| Yield CAGR 5y | 1.32% |
| Payout Consistency | 71.8% |
| Payout Ratio | 54.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 24.5% |
| Value at Risk 5%th | 39.9% |
| Relative Tail Risk | -1.02% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.27 |
| Alpha | -35.19 |
| CAGR/Max DD | -0.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.303 |
| Beta | 0.143 |
| Beta Downside | -0.036 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.30% |
| Mean DD | 21.90% |
| Median DD | 21.16% |
Description: CPB Campbell’s January 07, 2026
The Campbell Company (NYSE: CPB) manufactures and markets a broad portfolio of food and beverage brands across two primary segments: Meals & Beverages, which supplies condensed soups, broths, sauces, juices and frozen entrées in the U.S. and Canada; and Snacks, which offers Pepperidge Farm, Goldfish, Snyder’s-of-Hanover, Kettle Brand and other snack products in North America and Latin America.
In FY 2023 the company generated roughly $11.5 billion in net sales, with the Snacks segment delivering a 6 % higher year-over-year growth rate than Meals & Beverages, reflecting the broader consumer shift toward on-the-go snacking. CPB’s gross margin has been pressured by rising commodity costs (potatoes, wheat, dairy) and inflation-sensitive pricing, while its dividend yield sits near 3 % with a payout ratio of about 55 %. Key economic drivers include discretionary-income trends, private-label competition, and the pace of e-commerce adoption in grocery channels.
For a deeper, data-driven look at CPB’s valuation assumptions and scenario analysis, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 578.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.14 > 1.0 |
| NWC/Revenue: -5.58% < 20% (prev -3.32%; Δ -2.27% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.13b > Net Income 578.0m |
| Net Debt (6.80b) to EBITDA (1.53b): 4.44 < 3 |
| Current Ratio: 0.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (299.0m) vs 12m ago -0.66% < -2% |
| Gross Margin: 29.97% > 18% (prev 0.31%; Δ 2966 % > 0.5%) |
| Asset Turnover: 64.93% > 50% (prev 61.38%; Δ 3.54% > 0%) |
| Interest Coverage Ratio: 3.27 > 6 (EBITDA TTM 1.53b / Interest Expense TTM 339.0m) |
Altman Z'' (< 1.1 .. > 2.6) 1.70
| A: -0.04 (Total Current Assets 2.56b - Total Current Liabilities 3.13b) / Total Assets 15.18b |
| B: 0.31 (Retained Earnings 4.77b / Total Assets 15.18b) |
| C: 0.07 (EBIT TTM 1.11b / Avg Total Assets 15.65b) |
| D: 0.42 (Book Value of Equity 4.77b / Total Liabilities 11.22b) |
| Altman-Z'' Score: 1.70 = BBB |
ValueRay F-Score (Strict, 0-100) 63.24
| 1. Piotroski: 5.0pt |
| 2. FCF Yield: 4.63% |
| 3. FCF Margin: 6.76% |
| 4. Debt/Equity: 1.76 |
| 5. Debt/Ebitda: 4.44 |
| 6. ROIC - WACC: 3.78% |
| 7. RoE: 14.78% |
| 8. Revenue Trend: 58.19% |
| 9. EPS Trend: 5.99% |
What is the price of CPB shares?
As of January 23, 2026, the stock is trading at USD 26.20 with a total of 5,570,670 shares traded.
Over the past week, the price has changed by -2.28%, over one month by -6.85%, over three months by -14.40% and over the past year by -29.52%.
Over the past week, the price has changed by -2.28%, over one month by -6.85%, over three months by -14.40% and over the past year by -29.52%.
Is CPB a buy, sell or hold?
Campbell’s has received a consensus analysts rating of 3.13.
Therefor, it is recommend to hold CPB.
- Strong Buy: 4
- Buy: 2
- Hold: 12
- Sell: 3
- Strong Sell: 2
What are the forecasts/targets for the CPB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32 | 22.1% |
| Analysts Target Price | 32 | 22.1% |
| ValueRay Target Price | 25.4 | -3.2% |
CPB Fundamental Data Overview January 17, 2026
P/E Trailing = 13.866
P/E Forward = 10.7991
P/S = 0.7895
P/B = 2.02
P/EG = 0.6586
Revenue TTM = 10.16b USD
EBIT TTM = 1.11b USD
EBITDA TTM = 1.53b USD
Long Term Debt = 6.10b USD (from longTermDebt, last quarter)
Short Term Debt = 874.0m USD (from shortTermDebt, last quarter)
Debt = 6.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.80b USD (from netDebt column, last quarter)
Enterprise Value = 14.82b USD (8.02b + Debt 6.97b - CCE 168.0m)
Interest Coverage Ratio = 3.27 (Ebit TTM 1.11b / Interest Expense TTM 339.0m)
EV/FCF = 21.58x (Enterprise Value 14.82b / FCF TTM 687.0m)
FCF Yield = 4.63% (FCF TTM 687.0m / Enterprise Value 14.82b)
FCF Margin = 6.76% (FCF TTM 687.0m / Revenue TTM 10.16b)
Net Margin = 5.69% (Net Income TTM 578.0m / Revenue TTM 10.16b)
Gross Margin = 29.97% ((Revenue TTM 10.16b - Cost of Revenue TTM 7.11b) / Revenue TTM)
Gross Margin QoQ = 29.59% (prev 30.37%)
Tobins Q-Ratio = 0.98 (Enterprise Value 14.82b / Total Assets 15.18b)
Interest Expense / Debt = 1.16% (Interest Expense 81.0m / Debt 6.97b)
Taxrate = 24.22% (62.0m / 256.0m)
NOPAT = 838.9m (EBIT 1.11b * (1 - 24.22%))
Current Ratio = 0.82 (Total Current Assets 2.56b / Total Current Liabilities 3.13b)
Debt / Equity = 1.76 (Debt 6.97b / totalStockholderEquity, last quarter 3.96b)
Debt / EBITDA = 4.44 (Net Debt 6.80b / EBITDA 1.53b)
Debt / FCF = 9.90 (Net Debt 6.80b / FCF TTM 687.0m)
Total Stockholder Equity = 3.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.69% (Net Income 578.0m / Total Assets 15.18b)
RoE = 14.78% (Net Income TTM 578.0m / Total Stockholder Equity 3.91b)
RoCE = 11.06% (EBIT 1.11b / Capital Employed (Equity 3.91b + L.T.Debt 6.10b))
RoIC = 7.63% (NOPAT 838.9m / Invested Capital 10.99b)
WACC = 3.85% (E(8.02b)/V(14.99b) * Re(6.44%) + D(6.97b)/V(14.99b) * Rd(1.16%) * (1-Tc(0.24)))
Discount Rate = 6.44% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 85.70% ; FCFF base≈713.0m ; Y1≈670.5m ; Y5≈627.8m
Fair Price DCF = 40.46 (EV 18.87b - Net Debt 6.80b = Equity 12.06b / Shares 298.1m; r=5.90% [WACC]; 5y FCF grow -7.64% → 2.90% )
EPS Correlation: 5.99 | EPS CAGR: 2.97% | SUE: 1.47 | # QB: 3
Revenue Correlation: 58.19 | Revenue CAGR: 5.26% | SUE: 0.71 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.59 | Chg30d=-0.000 | Revisions Net=-5 | Analysts=14
EPS current Year (2026-07-31): EPS=2.43 | Chg30d=-0.004 | Revisions Net=-3 | Growth EPS=-18.1% | Growth Revenue=-2.9%
EPS next Year (2027-07-31): EPS=2.62 | Chg30d=-0.010 | Revisions Net=-5 | Growth EPS=+7.6% | Growth Revenue=+1.0%
P/E Forward = 10.7991
P/S = 0.7895
P/B = 2.02
P/EG = 0.6586
Revenue TTM = 10.16b USD
EBIT TTM = 1.11b USD
EBITDA TTM = 1.53b USD
Long Term Debt = 6.10b USD (from longTermDebt, last quarter)
Short Term Debt = 874.0m USD (from shortTermDebt, last quarter)
Debt = 6.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.80b USD (from netDebt column, last quarter)
Enterprise Value = 14.82b USD (8.02b + Debt 6.97b - CCE 168.0m)
Interest Coverage Ratio = 3.27 (Ebit TTM 1.11b / Interest Expense TTM 339.0m)
EV/FCF = 21.58x (Enterprise Value 14.82b / FCF TTM 687.0m)
FCF Yield = 4.63% (FCF TTM 687.0m / Enterprise Value 14.82b)
FCF Margin = 6.76% (FCF TTM 687.0m / Revenue TTM 10.16b)
Net Margin = 5.69% (Net Income TTM 578.0m / Revenue TTM 10.16b)
Gross Margin = 29.97% ((Revenue TTM 10.16b - Cost of Revenue TTM 7.11b) / Revenue TTM)
Gross Margin QoQ = 29.59% (prev 30.37%)
Tobins Q-Ratio = 0.98 (Enterprise Value 14.82b / Total Assets 15.18b)
Interest Expense / Debt = 1.16% (Interest Expense 81.0m / Debt 6.97b)
Taxrate = 24.22% (62.0m / 256.0m)
NOPAT = 838.9m (EBIT 1.11b * (1 - 24.22%))
Current Ratio = 0.82 (Total Current Assets 2.56b / Total Current Liabilities 3.13b)
Debt / Equity = 1.76 (Debt 6.97b / totalStockholderEquity, last quarter 3.96b)
Debt / EBITDA = 4.44 (Net Debt 6.80b / EBITDA 1.53b)
Debt / FCF = 9.90 (Net Debt 6.80b / FCF TTM 687.0m)
Total Stockholder Equity = 3.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.69% (Net Income 578.0m / Total Assets 15.18b)
RoE = 14.78% (Net Income TTM 578.0m / Total Stockholder Equity 3.91b)
RoCE = 11.06% (EBIT 1.11b / Capital Employed (Equity 3.91b + L.T.Debt 6.10b))
RoIC = 7.63% (NOPAT 838.9m / Invested Capital 10.99b)
WACC = 3.85% (E(8.02b)/V(14.99b) * Re(6.44%) + D(6.97b)/V(14.99b) * Rd(1.16%) * (1-Tc(0.24)))
Discount Rate = 6.44% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 85.70% ; FCFF base≈713.0m ; Y1≈670.5m ; Y5≈627.8m
Fair Price DCF = 40.46 (EV 18.87b - Net Debt 6.80b = Equity 12.06b / Shares 298.1m; r=5.90% [WACC]; 5y FCF grow -7.64% → 2.90% )
EPS Correlation: 5.99 | EPS CAGR: 2.97% | SUE: 1.47 | # QB: 3
Revenue Correlation: 58.19 | Revenue CAGR: 5.26% | SUE: 0.71 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.59 | Chg30d=-0.000 | Revisions Net=-5 | Analysts=14
EPS current Year (2026-07-31): EPS=2.43 | Chg30d=-0.004 | Revisions Net=-3 | Growth EPS=-18.1% | Growth Revenue=-2.9%
EPS next Year (2027-07-31): EPS=2.62 | Chg30d=-0.010 | Revisions Net=-5 | Growth EPS=+7.6% | Growth Revenue=+1.0%
Additional Sources for CPB Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle